Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.

J Oncol · 2010 · PMC3022192 · PMID 21274259

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although differences in survival endpoints did not reach statistical significance between these groups, there are many contributing factors to small retrospective analyses, such as inappropriate patient selection and/or reporter bias compounding the analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.